Immunomodulation by Lead

Immunologic Research

Volumn 28, Issue 2, 2003, Pages 151-165

  Singh, Vijay K ^a,d   Mishra, Kamla P ^a   Rani, Reena ^a   Yadav, Virendra S ^a   Awasthi, Sudhir K ^b   Garg, Satyendra K ^c  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b CSM University Kanpur   (India)

^c DR RAM MANOHAR LOHIA AVADH UNIVERSITY   (India)

^d ARMED FORCES RADIOBIOLOGY RESEARCH INSTITUTE   (United States)

Author keywords

Chemotaxis; Cytokines; Lead; Lymphocytes; NK cells

Indexed keywords

CHEMOKINE; CYTOKINE; GAMMA INTERFERON; LEAD; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

B LYMPHOCYTE; CELLULAR IMMUNITY; CHEMOKINESIS; CHEMOTAXIS; CYTOKINE PRODUCTION; CYTOTOXICITY; GENE EXPRESSION; HUMAN; HUMORAL IMMUNITY; IMMUNOMODULATION; LEAD POISONING; MITOGENICITY; NATURAL KILLER CELL; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; THYMUS;

ANIMALS; B-LYMPHOCYTES; CHEMOTAXIS, LEUKOCYTE; HUMANS; KILLER CELLS, NATURAL; LEAD; NEUROIMMUNOMODULATION; NITRIC OXIDE; PHAGOCYTOSIS; T-LYMPHOCYTES;

EID: 0345257360     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1385/IR:28:2:151     Document Type: Review

References (106)

1. Koller LD: Immunotoxicology of heavy metals. Int J Immunopharmacol 1980;2:269-279.
2. Cohen MD, Yang Z, Zelikoff JT: Immunotoxicity of particulate lead: In vitro exposure alters pulmonary macrophage tumor necrosis factor production and activity. J Toxicol Environ Health 1994;42:377-392.
3. Rabinowitz MB, Wetherill GW, Kopple JD: Magnitude of lead intake from respiration by normal man. J Lab Clin Med 1977;90:238-248.
4. Kishikawa H, Song R, Lawrence DA: Interleukin-12 promotes enhanced resistance to Listeria monocytogenes infection of lead exposed mice. Toxicol Appl Pharmacol 1997;147:180-189.
5. Koller LD, Kerkvliet NI, Exon JH: Neoplasia induced in male rats fed lead acetate, ethyl urea, and sodium nitrite. Toxicol Pathol 1985;13:50-57.
6. Snyder JE, Filipov NM, Parsons PJ, Lawrence DA: The efficiency of maternal transfer of lead and its influence on plasma IgE and splenic cellularity of mice. Toxicol Sci 2000;57:87-94.
7. + T cell subsets. Toxicol Appl Pharmacol 1991;111:13-23.
8. Ochel M, Vohr HW, Pfeiffer C, Gleichmann E: IL-4 is required for the IgE and IgG1 increase and IgG1 auto-antibody formation in mice treated with mercuric chloride. 1991;146:3006-3011.
9. 2 and gold sodium thiomalate enhance serum IgE and IgG concentrations in susceptible mouse strains. Int Arch Allergy App Immunol 1989;90:47-53.
10. Lawrence DA: Posited mechanisms of metal immunotoxicity. Hum Exp Toxicol 1995;14:114-116.
11. Kaye WE, Novotny TE, Tucker M: New ceramics-related industry implicated in elevated blood lead levels in children. Arch Environ Health 1987;42:161-164.
12. Goldman RH, Baker EL, Hannan M, Kamerow DB: Lead poisoning in automobile radiator mechanics. N Engl J Med 1987;317:214-218.
13. Singh B, Dhawan D, Nehru B, Garg ML, Mangal PC, Chand B, Trehan PN: Impact of lead pollution on the status of other trace metals in blood and alteration in hepatic functions. Biol Trace Elem Res 1994; 40:21-29.
14. Rudolf L, Sharp DS, Samuels S, Perkins C, Rosenberg J: Environmental and biological monitoring for lead exposure in California workplaces. Am J Public Health 1990;80:921-925.
15. ++ on protein kinase C isozymes. Toxicol Appl Pharmacol 1999;156:40-45.
16. Goldstein GW: Evidence that lead acts as a calcium substitute in second messenger metabolism. Neurotoxicology 1993;14:97-102.
17. Simons TJB: Lead-calcium interactions in cellular lead toxicity. Neurotoxicology 1993;14:77-86.
18. Loffert D, Ehlich A, Muller W, Rajewsky K: Surrogate light chain expression is required to establish immunoglobulin heavy chain allelic exclusion during early B cell development. Immunity 1996;4:133-144.
19. Rolink A, Melchers F: B lymphopoiesis in the mouse. Adv Immunol 1993;53:123-156.
20. Spangrude GJ: Biological and clinical aspects of hematopoietic stem cells. Annu Rev Med 1994;45: 93-104.
21. Ehlich A, Kuppers R: Analysis of immunoglobulin gene rearrangements in single B cells. Curr Opin Immunol 1995;7:281-284.
22. Kee BL, Paige CJ: Murine B cell development: commitment and progression from multipotential progenitors to mature B-lymphocytes. Int Rev Cytol 1995;157: 129-179.
23. Lam KP, Kuhn R, Rajewsky K: In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell 1997; 90:1073-1083.
24. ten Boekel E, Melchers F, Rolink A: The status of Ig loci rearrangements in single cells from different stages of B cell development. Int Immunol 1995;7:1013-1019.
25. Loffert D, Schaal S, Ehlich A, Hardy RR, Zou YR, Muller W, Rajewsky K: Early B-cell development in the mouse: insights from mutations introduced by gene targeting. Immunol Rev 1994;137:135-153.
26. Horne MC, Roth PE, DeFranco AL: Assembly of the truncated immunoglobulin heavy chain D mu into antigen receptor-like complexes in pre-B cells but not in B cells. Immunity 1996;4:145-158.
27. Takeda S, Sonoda E, Arakawa H: The kappa:lambda ratio of immature B cells. Immunol Today 1996;17: 200-201.
28. Leu TM, Eastman QM, Schatz DG: Coding joint formation in a cell-free V(D)J recombination system. Immunity 1997;7:303-314.
29. Koller LD: Immunosuppression produced by lead, cadmium and mercury. Am J Vet Res 1973;34:1457-1458.
30. Koller LD, Kovacic S: Decreased antibody formation to lead. Nature 1974;250:148-150.
31. Faith RE, Luster MI, Kimmel CA: Effect of chronic developmental lead exposure on cell mediated immune functions. Clin Exp Immunol 1979;35:413-420.
32. Luster MI, Faith RE, Kimmel CA: Depression of humoral immunity in rats following chronic developmental lead exposure. J Environ Pathol Toxicol 1978; 1:397-402.
33. McCabe MJ Jr, Lawrence DA: The heavy metal lead exhibits B cell stimulatory factor activity by enhancing B cell IgA expression and differentiation. J Immunol 1990;145:671-677.
34. McCabe MJ Jr, Dias JA, Lawrence, DA: Lead influences translational or posttranslational regulation of Ia expression and increases invariant chain expression in mouse B cells. J Biochem Toxicol 1991;6:269-276.
35. Lawrence DA: In vivo and in vitro effects of lead on humoral and cell mediated immunity. Infect Immun 1981;31:136-143.
36. Hillam RP, Ozkan AN: Comparison of local and systemic immunity after intratracheal, intraperitoneal and intravenous immunization of mice exposed to either aerosolized or ingested lead. Environ Res 1986;39: 265-277.
37. Boscolo P, Di Gioacchino M, Sabbioni E, Benvenuti F, Conti P, Reale M, et al: Expression of lymphocyte subpopulations, cytokine serum levels and blood and urinary trace elements in asymptomatic atopic men exposed to an urban environment. Int Arch Occup Environ Health 1999;72:26-32.
38. Boscolo P, Di Gioacchino M, Sabbioni E, Di Giacomo F, Reale M, Volpe AR, et al.: Lymphocyte subpopulations, cytokines and trace elements in asymptomatic atopic women exposed to an urban environment. Life Sci 2000;67:1119-1126.
39. Lutz PM, Wilson TJ, Ireland J, Jones AL, Gorman JS, Gale NL, et al.: Elevated immunoglobulin E (IgE) levels in children with exposure to environmental lead. Toxicology 1999;3:63-78.
40. Miller TE, Golemboski KA, Ha RS, Bunn T, Sanders FS, Dietert RR: Developmental exposure to lead causes persistent immunotoxicity in Fisher 344 rats. Toxicol Sci 1998;42:129-135.
41. Ewers U, Stiller-Winkler R, Idel H: Serum immunoglobulin, complement C3 and salivary IgA levels in lead workers. Environ Res 1982;29:352-357.
42. Waterman SJ, el-Fawal HA, Snyder CA: Lead alters the immunogenicity of two neural proteins: a potential mechanism for the progression of lead-induced neurotoxicity. Environ Health Perspect 1994;102:1052-1056.
43. Cordier AC, Haumont SM: Development of thymus, parathyroids, and ultimo-branchial-bodies in NMRI and nude mice. Am J Anat 1980;157:227-263.
44. Nehls M, Kyewski B, Messerle M, Waldschutz R, Schuddekopf K, Smith AJ, Boehm T: Two genetically separable steps in the differentiation of thymic epithelium. Science 1996;272:886-889.
45. van Ewijk W: T-cell differentiation is influenced by thymic microenvironments. Annu Rev Immunol 1991;9: 591-615.
46. Anderson G, Moore NC, Owen JJ, Jenkinson EJ: Cellular interactions in thymocyte development. Annu Rev Immunol 1996;14:73-99.
47. Zuniga-Pflucker JC, Lenardo MJ: Regulation of thymocyte development from immature progenitors. Curr Opin Immunol 1996;8:215-224.
48. Petrie HT, Hugo P, Scollay R, Shortman K: Lineage relationships and developmental kinetics of immature thymocytes: CD3, CD4, and CD8 acquisition in vivo and in vitro. J Exp Med 1990;172:1583-1588.
49. Shortman K, Wu L: Early T lymphocyte progenitors. Annu Rev Immunol 1996;14:29-47.
50. Huesmann M, Scott B, Kisielow P, von Boehmer H: Kinetics and efficacy of positive selection in the thymus of normal and T cell receptor transgenic mice. Cell 1991;66:533-540.
51. Surh CD, Sprent J: T-cell apoptosis detected in situ during positive and negative selection in the thymus. Nature 1994;372:100-103.
52. Fink PJ, Bevan MJ: H-2 antigens of the thymus determine lymphocyte specificity. J Exp Med 1978;148-766-775.
53. Hogquist KA, Tomlinson AJ, Kieper WC, McGargill MA, Hart MC, Naylor S, Jameson SC: Identification of a naturally occurring ligand for thymic positive selection. Immunity 1997;6:389-399.
54. Ignatowicz L, Kappler J, Marrack P: The repertoire of T cells shaped by a single MHCpeptide ligand. Cell 1996;84:521-529.
55. Zinkernagel RM, Callahan GN, Klein J, Dennert G: Cytotoxic T cells learn specificity for self H-2 during differentiation in the thymus. Nature 1978;271:251-253.
56. Koller LD, Roan JG, Kerkvliet NI: Mitogen stimulation of lymphocytes in CBA mice exposed to lead and cadmium. Environ Res 1979;19:177-188.
57. Alomran AH, Shleanmoon MN: The influence of chronic lead exposure on lymphocyte proliferative response and immunoglobulin levels in storage battery workers. J Biol Sci Res 1988;19:575-585.
58. Kimber I, Jackson JA, Stonards MD: Failure of inorganic lead exposure to impair natural killer (NK) cell andT lymphocyte function in rats. Toxicol Lett 1986;31: 211-218.
59. Querioz ML, Almedia M, Gallo MI, Hochr NF: Defective neutrophil function in workers occupationally exposed to lead. Pharmacol Toxicol 1993;72:73-77.
60. Hambach A, Stiller-Winkler R, Oberbarnscheidt J, Ewers U: Are suppressor T cells the primary target cells of lead immunotoxicity? Zentralbl Bakteriol Mikrobiol Hyg 1983;178:316-328.
61. Laschi-Loquerie A, Descotes J, Tachon P, Evreux JC: Influence of lead acetate on hypersensitivity. Exp Study 1984;6:87-93.
62. 2 lymphocytes. Toxicol Sci 1998;43:172-185.
63. Gerondakis S, Grumont R, Rourke I, Grossman M: The regulation and roles of RelNF-κB transcription factors during lymphocyte activation. Curr Opin Immunol 1998;10:353-359.
64. + T lymphocytes. Biochem Biophys Res Commun 1996; 227:380-385.
65. Herberman RB, Holden HT: Natural cell mediated immunity. Adv Cancer Res 1978;27:305-377.
66. Whiteside TL: Natural Killer Cells. Encyclopedia of immunology. 1998:1809-1815.
67. Kimber I, Stonard MD, Gidlow DA, Niewola Z: Influence of chronic low-level exposure to lead on plasma immunoglobulin concentration and cellular immune function in man. Int Arch Occup Environ Health 1986; 57:117-125.
68. Yucesoy B, Turhan A, Ure M, Imir T, Karakaya A: Effects of occupational lead and cadmium exposure on some immunoregulatory cytokine levels in man. Toxicology 1997;123:143-147.
69. + cells and functional impairments of lymphocytes at low-level occupational exposure to lead. Clin Immunol Immunopathol 1993;66:163-168.
70. Exon JH, Talcott PA, Koller LD: Effect of lead polychlorinated-biphenyls and cyclophosphamide on rat natural killer cells, interleukin-2 and antibody synthesis. Fundam Appl Toxicol 1985;1:158-164.
71. Kaminska T, Filar J, Madej E, Szuster-Ciesielska A, Kandefer-Szerszen M: Modification of bovine interferon and tumor necrosis factor production by lead in vivo and in vitro. Arch Immunol Ther Exp (Warsz) 1998;46:323-328.
72. Milosevic N, Maier P: Lead stimulate intercellular signaling between hepatocytes and kupffer cells. Eur J Pharmacol 2000;401:317-328.
73. Kim D, Lawrence DA: Immunotoxic effects of inorganic lead on host resistance of mice with different circling behaviors preferences. Brain Behav Immunol 2000;14:305-317.
74. Chen S, Golemboski KA, Sanders FS, Dietert RR: Persistent effect of in utero meso 2,3-dimercaptosuccinic acid (DMSA) on immune function and lead induced immunotoxicity. Toxicology 1999;132:67-79.
75. Goebel C, Flohe SB, Kirchhoff K, Herder C, Kolb H: Orally administered lead chloride induces bias of mucosal immunity. Cytokine 2000;12:1414-1418.
76. Sata F, Araki S, Tanigawa T, Morita Y, Sakurai S, Katsuno N: Changes in natural killer cell subpopulations in lead workers. Int Arch Occup Environ Health 1997; 69:306-310.
77. Sata F, Araki S, Tanigawa T, Morita Y, Sakurai S, Nakata A, Katsuno N: Changes in T cell subpopulations in lead workers. Environ Res 1998;76:61-64.
78. Coscia GC, Discalzi G, Ponzetti C: Immunological aspects of occupational lead exposure. Med Lav 1987;78: 360-364.
79. Pinkerton LE, Biagini RE, Ward EM, Hull RD, Deddens JA, Boeniger MF, et al.: Immunologic findings among lead exposed workers. Am J Ind Med 1998;33: 400-408.
80. Valentino M, Governa M, Marchiseppe I, Visona I: Effect of lead on polymorphonuclear leucocyte (PMN) functions in occupationally exposed workers. Arch Toxicol 1991;65:685-688.
81. Governa M, Valentino M, Visona I, Scielso R: Impairment of chemotaxis of polymorphonuclear leukocytes from lead acid battery workers. Sci Total Environ 1988; 71:543-546.
82. Governa M, Valentino M, Visona I: In vitro impairment of human granulocyte functions by lead. Arch Toxicol 1987;59:421-425.
83. Knowles SO, Donaldson WE: Lead disrupts eicosanoid metabolism, macrophage function and disease resistance in birds. Biol Trace Elem Res 1997;60:13-26.
84. Zelikoff JT, Parsons E, Schlesinger RB: Inhalation of particulate lead oxide disrupts pulmonary macrophage-mediated functions important for host defense and tumour surveillance in the lung. Environ Res 1993;62: 207-222.
85. Johnston RB Jr: Current concepts: immunology: monocyte and macrophages. N Engl J Med 1988;318:747-752.
86. Hibbs JB Jr, Taintor RR, Vavrin Z, Rachlin EM: Nitric oxide: a cytotoxic macrophage effector molecule. Biochem Biophys Res Commun 1988;157:87-94.
87. Sorg C: Macrophage in acute and chronic inflammation. Chest 1991;100:173S-175S.
88. Laskin JD, Heck DE, Laskin DL: Multifunctional role of nitric oxide in inflammation. Trends Endocrinol 1994; 5:377-382.
89. Nathan C: Nitric oxide as a secretory product of mammalian cells. FASEB J 1992;6:3051-3064.
90. Moncada S, Palmer RMJ, Higgs EA: Biosynthesis of nitric oxide from L-arginine. A pathway for the regulation of cell function and communication. Biochem Pharmacol 1989;38:1709-1715.
91. Snyder SH: Nitric oxide: first in a new class of neurotransmitters? Science 1992;257:494-496.
92. Moncada S, Palmer RM, Higgs EA: Nitric oxide physiology, pathophysiology and pharmacology. Pharmacol Rev 1991;43:109-142.
93. Forstermann U, Schmidt HH, Pollock JS, Mitchell JA, Warner TD, Nakane M, Murad F: Isoforms of nitric oxide synthase. Characterization and purification from different cell types. Biochem Pharmacol 1991;42:1849-1857.
94. Stuehr DJ, Griffith OW: Mammalian nitric oxide synthases. Adv Enzymol Relat Areas Mol Biol 1992;65: 287-346.
95. Bredt DS, Snyder SH: Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc Natl Acad Sci USA 1989;86:9030-9033.
96. Kilbourn RG, Belloni P: Endothelial cell production of nitrogen oxides in response to interferon-γ in combination with tumor necrosis factor, interleukin-1, or endotoxin. J Natl Cancer Inst 1990;82:772-776.
97. Bereta M, Bereta J, Cohen S, Cohen MC: Low-density lipoprotein inhibits accumulation of nitrites in murine brain endothelial cell cultures. Biochem Biophys Res Commun 1992;186:315-320.
98. Bredt DS, Snyder SH: Nitric oxide, a novel neuronal messenger. Neuron 1992;8:3-11.
99. Dimmeler S, Haendeler J, Nehls M, Zeiher AM: Suppression of apoptosis by nitric oxide via inhibition of interleukin-1β converting enzyme (ICE)-like and cysteine protease protein (CPP)-32 like proteases. J Exp Med 1997;185:601-607.
100. Okuda Y, Sakoda S, Shimoaka M, Yanagihara T: Nitric oxide induces apoptosis in mouse splenic T lymphocytes. Immunol Lett 1996;52:135-138.
101. Blazka ME, Harry GJ, Luster MI: Effect of lead acetate on nitrite production by murine brain endothelial cell cultures. Toxicol Appl Pharmacol 1994;126:191-194.
102. Tian L, Lawrence DA: Lead inhibits nitric oxide production in vitro by murine splenic macrophages. Toxicol Appl Pharmacol 1995;132:156-163.
103. Tian L, Lawrence DA: Metal induced modulation of nitric oxide production in vitro by murine macrophages: lead, nickel and cobalt utilize different mechanism. Toxicol Appl Pharmacol 1996;141:540-547.
104. Kanematsu M, Takagi K, Masuda N, Suketa Y: Lead inhibits nitric oxide production transiently by mRNA level in murine macrophage cell lines. Biol Pharm Bull 1996;19:949-951.
105. Rosenkranz-Weiss P, Sessa WC, Milstien S, Kaufman S, Watson CA, Pober JS: Regulation of nitric oxide synthesis by proinflammatory cytokines in human umbilical vein endothelial cells. Elevation in tetrahydrobiopterin levels enhances endothelial nitric oxide synthase specific activity. J Clin Invest 1994;93: 2236-2243.
106. Song JS, Sim SY, Hong DP, Dal Rhee S, Song CW, Han SS, Yang SD: Lead treatment in vitro at early developmental stage of bone marrow derived macrophages enhances NO production through IL-1β and IL-6 but not TNF-α. Toxicology 2001;162:61-68.